Novartis AG vs SoundHound AI Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while SoundHound AI Inc trades at $7.44 (market cap $3.29B). The key difference: Novartis AG is far larger — about 89.8× SoundHound AI Inc's market cap, and Novartis AG pays a 3.07% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.
| NVS | SOUN | |
|---|---|---|
Market Cap | $295.37B | $3.29B |
Sector | Health | Technology |
52-Week High | $168.62 | $21.40 |
52-Week Low | $119.31 | $5.70 |
Enterprise Value | $336.69B | $3.09B |
Dividend Yield | 3.07% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →